Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Price cut secures a place for Ipsen’s Cabomeytx on the NHS

Ipsen has cut the price of its kidney cancer Cabometyx to help secure its place within the NHS’ routine commissioning stream, helping to over-turn a previous decision that it did not represent value for money.

Read the rest of entry »

Oxford BioMedica signs major supply deal with Novartis

Oxford BioMedica has sealed a major deal with Novartis to supply the Swiss drug giant with lentiviral vectors used to create cell therapy products, including CTL019 and other undisclosed Chimeric Antigen Receptor T cell (CART) products.

Read the rest of entry »

Lilly victorious in Alimta patent case

Eli Lilly has welcomed a decision by the UK Supreme Court that alternative salt forms of its cancer drug Alimta.

Read the rest of entry »

Isansys’ ‘washable’ high-tech patient sensors feature in the Government’s latest Great Britain campaign

Isansys Lifecare is delighted to announce that we have been chosen to feature in the Government's “GREAT for Imagination” campaign.

Read the rest of entry »

Immunocore and MEPC announce significant laboratory expansion at Milton Park in Oxfordshire, UK

Additional space will provide purpose-built research laboratories accommodating around 450 scientists at Immunocore

Read the rest of entry »

Spinning Out Success

OxStem is the largest spin-out company to date to emerge from the University of Oxford's Department of Chemistry.

Read the rest of entry »

Commercializing Cell and Gene Therapies

It takes a commitment to innovation, seamless coordination and the support of an experienced partner to overcome every barrier on the journey from clinical to commercial success.

Read the rest of entry »

Precision for Medicine Expands Its Global Footprint for Oncology Development Services

Leadership in place; Clinical Operations teams growing throughout Europe

BETHESDA, Md., July 6, 2017 /PRNewswire/ -- Precision for Medicine today reported important progress in its global expansion plan. Precision for Medicine, with its oncology research team Precision Oncology, is rapidly expanding its global footprint to better serve clients developing oncology treatments. Investment in executive leadership and operational teams are underway across Europe, providing integrated, full-service clinical trial execution services throughout the continent.

Read the rest of entry »

Devising an efficient roadmap for early stage & start-up companies to maximise value & chances of success

OBN BioTuesday Pennington Manches

Read the rest of entry »

Wickham Laboratories Now Offering Full Suite of Medical Device Biocompatibility and Safety Testing

Medical device testing is one of the most complex services offered in the life sciences sector, both for the diversity of the product tested and for the different level of safety or biocompatibility required prior to approval for use in patients.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.